MoonLake Immunotherapeutics: And The Press Release Attached Hereto As Exhibit 99.1, Insofar As They Disclose Information Regarding The Company’s Results Of Operation And Financial Condition For The Quarter Ended September30, 2025, Are Being Furnished To The U.s. Securities And Exchange Commission (“sec”), Regulation Fd Disclosure, Financial Statements And Exhibits

Mostra articolo completo

Questa funzionalità è disponibile solo per gli utenti registrati

• Nome completo dell'emittente
  MoonLake Immunotherapeutics (formerly Helix Acquisition Corp)
• Paese di registrazione
  Cayman Islands
• Settore industriale
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***